Boxer Capital LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-25 4:31 pm Sale |
2024-01-23 | 13D | Mirati Therapeutics, Inc. MRTX |
Boxer Capital LLC | 0 0.000% |
-11,661,726 (Position Closed) |
Filing |
| 2023-10-12 1:07 pm Unchanged |
2023-10-08 | 13D | Mirati Therapeutics, Inc. MRTX |
Boxer Capital LLC | 11,661,726 15.900% |
0 (Unchanged) |
Filing |
| 2023-08-16 4:28 pm Purchase |
2023-08-11 | 13D | Mirati Therapeutics, Inc. MRTX |
Boxer Capital LLC | 11,661,726 15.900% |
1,370,879 (+13.32%) |
Filing |
| 2020-10-30 9:44 pm Purchase |
2020-10-28 | 13D | Mirati Therapeutics, Inc. MRTX |
Boxer Capital LLC | 10,290,847 18.900% |
1,522,564 (+17.36%) |
Filing |